NovaBay Pharmaceuticals, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $495K, a 1.2% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $495K -$6K -1.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $476K -$20K -4.03% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $477K -$1K -0.21% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $478K -$11K -2.25% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $501K +$348K +227% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $496K +$340K +218% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $478K +$317K +197% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $489K +$13K +2.73% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $153K -$323K -67.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $156K -$319K -67.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $161K -$315K -66.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $476K $0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $476K $0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $475K -$2K -0.42% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $476K $0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $476K -$1K -0.21% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $476K -$66K -12.2% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $477K -$65K -12% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $476K -$66K -12.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $477K -$75K -13.6% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $542K -$24K -4.24% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $542K -$40K -6.87% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $542K -$55K -9.21% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $552K -$61K -9.95% Dec 31, 2018 10-K 2020-03-26
Q3 2018 $566K -$60K -9.59% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $582K -$59K -9.2% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $597K -$133K -18.2% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $613K +$74K +13.7% Dec 31, 2017 10-K 2019-03-29
Q3 2017 $626K +$187K +42.6% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $641K +$576K +886% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $730K Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $539K +$384K +248% Dec 31, 2016 10-K 2018-03-21
Q3 2016 $439K +$285K +185% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $65K -$88K -57.5% Jun 30, 2016 10-Q 2016-08-11
Q4 2015 $155K +$6K +4.03% Dec 31, 2015 10-K 2017-03-23
Q3 2015 $154K +$7K +4.76% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $153K +$7K +4.8% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $151K +$7K +4.86% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $149K +$8K +5.67% Dec 31, 2014 10-K 2016-03-04
Q3 2014 $147K +$73K +98.6% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $146K +$72K +97.3% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $144K +$81K +129% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 $141K +$78K +124% Dec 31, 2013 10-K 2015-03-26
Q3 2013 $74K -$43K -36.8% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $74K -$43K -36.8% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $63K -$42K -40% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 $63K -$72K -53.3% Dec 31, 2012 10-K 2014-03-06
Q3 2012 $117K -$27K -18.8% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $117K -$31K -20.9% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $105K Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $135K -$39K -22.4% Dec 31, 2011 10-K 2013-03-14
Q3 2011 $144K Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $148K Jun 30, 2011 10-Q 2011-08-10
Q4 2010 $174K Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.